Editöre Mektup
BibTex RIS Kaynak Göster

Veno-venous ECMO in patient with COVID-19 severe pneumonia

Yıl 2020, , 1 - 2, 20.05.2020
https://doi.org/10.7197/cmj.vi.728082

Öz

Since December 2019 we have been faced with a rapidly growing number of patients with COVID-19, which is caused by the SARS-CoV-2 coronavirus. According to the Centers for Disease Control and Prevention (CDC), COVID-19 is a respiratory illness. A person may have a dry cough, fever, muscle aches, and fatigue. Most common diagnosis for severe COVID-19 is severe pneumonia which may be life threatening . In most cases, antiviral, antimicrobial, and steroidal treatment is applied in these patients. However, some cases are resistant to treatment. Then the use of extracorporeal oxygenation membranes (ECMO) may be helpful.

Kaynakça

  • 1. Smereka J, Szarpak L, Filipiak KJ. Modern medicine in COVID-19 era. Disaster Emerg Med J 2020; 5(2); DOI: 10.5603/DEMJ.a2020.0012 2. Dzieciatkowski T, Szarpak L, Filipiak KJ, Jaguszewski M, Ladny JR, Smereka J. COVID-19 challenge for modern medicine. Cardiol J. 2020 Apr 14. doi: 10.5603/CJ.a2020.0055. 3. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924 4. Smereka J, Puslecki M, Ruetzler K, et al. Extracorporeal membrane oxygenation in COVID-19. Cardiol J. 2020 Apr 14. doi: 10.5603/CJ.a2020.0053. 5. Pravda NS, Pravda MS, Kornowski R, Orvin K. Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic. Future Cardiol. 2020 Apr 17. doi: 10.2217/fca-2020-0040. 6. WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. 2020. . (accessed April 20, 2020) https://www.who.int/docs/default-source/coronaviruse/clinical-managementof-novel-cov.pdf. 7. Jacobs JP, Stammers AH, St Louis J. Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients. ASAIO J. 2020 Apr 17. doi: 10.1097/MAT.0000000000001185. 8. Burns KE, Adhikari NK, Slutsky AS, Guyatt GH, Villar J, Zhang H, Zhou Q, Cook DJ, Stewart TE, Meade MO. Pressure and volume-limited ventilation for the ventilatory management of patients with acute lung injury: a systematic review and meta-analysis. PLoS One. 2011;6:e14623. doi: 10.1371/journal.pone.0014623. 9. Luecke T, Pelosi P. Clinical review: Positive end-expiratory pressure and cardiac output. Crit Care. 2005;9:607–621. doi: 10.1186/cc3877.
Yıl 2020, , 1 - 2, 20.05.2020
https://doi.org/10.7197/cmj.vi.728082

Öz

Kaynakça

  • 1. Smereka J, Szarpak L, Filipiak KJ. Modern medicine in COVID-19 era. Disaster Emerg Med J 2020; 5(2); DOI: 10.5603/DEMJ.a2020.0012 2. Dzieciatkowski T, Szarpak L, Filipiak KJ, Jaguszewski M, Ladny JR, Smereka J. COVID-19 challenge for modern medicine. Cardiol J. 2020 Apr 14. doi: 10.5603/CJ.a2020.0055. 3. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924 4. Smereka J, Puslecki M, Ruetzler K, et al. Extracorporeal membrane oxygenation in COVID-19. Cardiol J. 2020 Apr 14. doi: 10.5603/CJ.a2020.0053. 5. Pravda NS, Pravda MS, Kornowski R, Orvin K. Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic. Future Cardiol. 2020 Apr 17. doi: 10.2217/fca-2020-0040. 6. WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. 2020. . (accessed April 20, 2020) https://www.who.int/docs/default-source/coronaviruse/clinical-managementof-novel-cov.pdf. 7. Jacobs JP, Stammers AH, St Louis J. Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients. ASAIO J. 2020 Apr 17. doi: 10.1097/MAT.0000000000001185. 8. Burns KE, Adhikari NK, Slutsky AS, Guyatt GH, Villar J, Zhang H, Zhou Q, Cook DJ, Stewart TE, Meade MO. Pressure and volume-limited ventilation for the ventilatory management of patients with acute lung injury: a systematic review and meta-analysis. PLoS One. 2011;6:e14623. doi: 10.1371/journal.pone.0014623. 9. Luecke T, Pelosi P. Clinical review: Positive end-expiratory pressure and cardiac output. Crit Care. 2005;9:607–621. doi: 10.1186/cc3877.
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Letters to the Editor
Yazarlar

Marek Dabrowski 0000-0003-1692-8578

Jacek Smereka 0000-0002-1427-4796

Togay Evrin 0000-0002-1235-9577

Burak Katipoglu 0000-0002-4347-6258

Anna Drozd 0000-0003-1949-4023

Lukasz Szarpak 0000-0002-0973-5455

Yayımlanma Tarihi 20 Mayıs 2020
Kabul Tarihi 28 Nisan 2020
Yayımlandığı Sayı Yıl 2020

Kaynak Göster

AMA Dabrowski M, Smereka J, Evrin T, Katipoglu B, Drozd A, Szarpak L. Veno-venous ECMO in patient with COVID-19 severe pneumonia. CMJ. Mayıs 2020;42(1):1-2. doi:10.7197/cmj.vi.728082